Hematopoietic Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem CellsStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationStem CellsHistocompatibilityTransplantation ChimeraBone Marrow TransplantationTissue DonorsHistocompatibility TestingCord Blood Stem Cell TransplantationGraft SurvivalTreatment OutcomeGraft vs Leukemia EffectMyeloablative AgonistsWhole-Body IrradiationLeukemiaHematopoiesisAntigens, CD34HLA AntigensSevere Combined ImmunodeficiencyHematopoietic Stem Cell MobilizationBusulfanRecurrenceRetrospective StudiesUnrelated DonorsChimerismLiver TransplantationSiblingsImmunosuppressive AgentsRemission InductionVidarabineLymphocyte DepletionLymphocyte TransfusionCell DifferentiationLeukemia, Myeloid, AcuteBone Marrow CellsMesenchymal Stem Cell TransplantationHematologic DiseasesHepatic Veno-Occlusive DiseaseDisease-Free SurvivalCombined Modality TherapySurvival RateMultiple MyelomaCell LineageCell TransplantationMyelodysplastic SyndromesStem Cell NicheTime FactorsT-LymphocytesEmbryonic Stem CellsAntilymphocyte SerumGraft vs Tumor EffectAdult Stem CellsFlow CytometryCyclophosphamideTransplantation ImmunologyPrecursor Cell Lymphoblastic Leukemia-LymphomaGranulocyte Colony-Stimulating FactorSurvival AnalysisMelphalanKidney TransplantationMice, Inbred C57BLBone MarrowFetal BloodTransplantation, IsogeneicColony-Forming Units AssayGraft RejectionAcute DiseaseSalvage TherapyHaploidyFollow-Up StudiesCytomegalovirus InfectionsHaplotypesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticDonor SelectionFetal TherapiesLiving DonorsAllograftsReceptors, KIRAntineoplastic Combined Chemotherapy ProtocolsCells, CulturedCell SeparationMesenchymal Stromal CellsPluripotent Stem Cells